Cucurmin, anticancer, & antitumor perspectives: A comprehensive review
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Cucurmin, a naturally yellow component isolated from turmeric, ability to prevent various life-style related disorders. The current review article mainly emphasizes on different anticancer perspectives of cucurmin, i.e., colon, cervical, uterine, ovarian, prostate head and neck, breast, pulmonary, stomach and gastric, pancreatic, bladder oral, oesophageal, and bone cancer. It holds a mixture of strong bioactive molecule known as cucurminoids that has ability to reduce cancer/tumor at initial, promotion and progression stages of tumor development. In particular, these compounds block several enzymes required for the growth of tumors and may therefore involve in tumor treatments. Moreover, it modulates an array of cellular progressions, i.e., nitric oxide synthetase activity, protein kinase C activity, epidermal growth factor (EGF) receptor intrinsic kinase activity, nuclear factor kappa (NF-kB) activity, inhibiting lipid peroxidation and production of reactive oxygen species. However, current manuscript summarizes most of the recent investigations of cucurmin but still further research should be conducted to explore the role of curcumin to mitigate various cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · cited 1×
“During normal homeostasis, nuclear transcription factor-kB (NF-kB) act as an inactive hetero trimer, exist in the cytoplasm and composed of IkB-a, p50 and p65 (Karin and Ben-Neriah, 2000).”
BackgroundActivators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 2×
“The three types of proteins encompasses to form IaB kinase complex, i.e., IKK-b, IKK-a, IKK-g/NF-kB essential modulator, for phosphorylating IkB-a, the kinases being responsible were IKK-b and IKK-a (Maute et al., 2009; Pahl, 1999).”
BackgroundMethodSTATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“In numerous cancers like endometrial and ovarian cancer it has been found that STAT-3 has a great constitutive activation (Bowman et al., 2000; Bromberg, 2000).”
BackgroundCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · cited 3×
“It also inhibits different objects such as NF-kB, COX-2 and kinases associated with endurance signaling (NIK, AKT and IKK), cell proliferation and cell cycle regulation (Aggarwal et al., 2003; Castedo et al., 2004).”
BackgroundMethod
Research works printed but not linked: 285
- 10.1006/phrs.1998.0404 · DOI · Paper page
- 10.1097/00001813-200503000-00005 · DOI · Paper page
- 10.1016/j.bcp.2006.12.010 · DOI
- Aggarwal B. B., 2003, Anticancer Res., 23, 363
- 10.1196/annals.1378.063 · DOI · Paper page
- 10.1002/ijc.20333 · DOI · Paper page
- 10.1016/j.biopha.2015.02.029 · DOI
- 10.1007/s10549-010-1089-3 · DOI
- 10.1371/journal.pone.0124218 · DOI
- 10.1093/carcin/23.1.143 · DOI · Paper page
- 10.1124/mol.106.033167 · DOI · Paper page
- 10.1097/jcp.0b013e318160862c · DOI · Paper page
- 10.1016/S0960-9822(98)70067-3 · DOI · Paper page
- 10.1155/2013/810423 · DOI
- 10.1186/1477-3155-5-3 · DOI · Paper page
- 10.1158/1535-7163.MCT-10-0172 · DOI · Paper page
- 10.1186/bcr38 · DOI
- 10.1200/JCO.2007.11.5345 · DOI · Paper page
- 10.1056/NEJM200004273421710 · DOI
- Calaf G., 2012, Int. J. Oncol., 40, 436
- Calaf G. M., 2011, Oncol. Rep., 26, 1029
- 10.1080/10286020.2014.951923 · DOI
- 10.1158/0008-5472.CAN-07-6805 · DOI · Paper page
- 10.1158/1940-6207.CAPR-09-0076 · DOI
- 10.1002/ijc.21967 · DOI · Paper page
- 10.1016/S0006-2952(98)00114-2 · DOI · Paper page
- 10.1002/ijc.25220 · DOI
- 10.1158/0008-5472.CAN-13-1778 · DOI
- 10.2174/1381612023394016 · DOI · Paper page
- 10.1016/j.bcp.2004.07.009 · DOI · Paper page
- 10.1016/j.jsbmb.2014.01.009 · DOI
- Cheng A.-L., 2001, Anticancer Res., 21, 2895
- Chiablaem K., 2014, Anticancer Res., 34, 1857
- 10.1097/00001813-200410000-00010 · DOI
- 10.1016/S0014-5793(02)02292-5 · DOI · Paper page
- 10.1016/S0278-6915(00)00101-0 · DOI · Paper page
- Chung S. S., 2015, Anticancer Res., 35, 39
- 10.1001/jama.1996.03540240035027 · DOI · Paper page
- 10.1001/jama.1996.03540240035027 · DOI · Paper page
- 10.1001/archotol.135.2.190 · DOI
- 10.1007/s13277-015-3178-8 · doi:10.1007/s13277-015-3178-8
- 10.3892/etm.2015.2240 · doi:10.3892/etm.2015.2240
- 10.1016/S0006-291X(02)00633-2 · DOI · Paper page
- 10.1002/jcb.25035 · DOI
- 10.1038/nrm2393 · DOI · Paper page
- Deng G., 2008, Zhonghua Nan Ke Xue, 14, 116
- 10.1371/journal.pone.0125627 · DOI
- 10.1021/mp400366r · DOI
- 10.1002/mc.20170 · DOI · Paper page
- 10.1002/pros.1074 · DOI · Paper page
- 10.4236/jct.2014.54044 · DOI
- 10.3892/mmr.2014.2551 · DOI
- 10.1158/1535-7163.MCT-10-0064 · doi:10.1158/1535-7163.mct-10-0064
- 10.1016/j.canlet.2004.09.041 · DOI · Paper page
- 10.3945/jn.108.100966 · DOI · Paper page
- 10.1097/00001813-199902000-00007 · DOI · Paper page
- 10.5483/BMBRep.2015.48.8.216 · DOI
- 10.7314/APJCP.2015.16.6.2473 · DOI
- 10.1371/journal.pone.0118702 · DOI
- 10.3892/or.2015.4044 · doi:10.3892/or.2015.4044
- 10.1016/j.ejphar.2015.03.076 · DOI
- 10.3390/molecules20023020 · DOI
- 10.1186/1471-2407-11-112 · DOI · Paper page
- 10.1097/CAD.0b013e32832afc04 · DOI
- 10.1006/bbrc.1997.7806 · DOI
- Gandhi P., 2011, J. Appl. Pharmaceut. Sci., 1, 1
- 10.1177/10454411900010030101 · doi:10.1177/10454411900010030101
- 10.1046/j.1365-2125.1998.00640.x · DOI
- 10.3109/07357900903287006 · DOI
- 10.1016/j.bcp.2007.08.016 · DOI · Paper page
- 10.4161/15384047.2014.986997 · doi:10.4161/15384047.2014.986997
- 10.1186/1743-7075-5-17 · DOI · Paper page
- Guo F., 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi. Chinese J. Integrated Traditional Western Med., 25, 1140
- 10.1002/ptr.5257 · DOI
- 10.1111/j.1440-1681.2011.05648.x · DOI · Paper page
- 10.3389/fphys.2015.00129 · DOI
- 10.1016/j.juro.2007.08.122 · DOI · Paper page
- Hirose Y., 1997, J. Cell. Biochem. Suppl., 27, 35
- 10.1093/carcin/1.10.861 · doi:10.1093/carcin/1.10.861
- Holmäng S., 2000, Semin. Urol. Oncol, 18, 273
- 10.1016/S1383-5718(02)00076-1 · DOI
- 10.1200/JCO.2006.06.4907 · DOI · Paper page
- Hong R.-L., 1999, Clin. Cancer Res., 5, 1884
- Hsu C.-H., Advances in Experimental Medicine and Biology, 471
- 10.1021/bk-1992-0507.ch027 · doi:10.1021/bk-1992-0507.ch027
- 10.1016/S0360-3016(01)02651-7 · DOI
- 10.1034/j.1600-0773.2003.920106.x · DOI · Paper page
- Ireson C., 2001, Cancer Res., 61, 1058
- Ireson C. R., 2002, Cancer Epidemiol. Biomarkers Prev., 11, 105
- 10.1186/1471-2407-12-27 · DOI
- 10.1016/j.canlet.2015.05.017 · DOI
- 10.1074/jbc.M310369200 · DOI · Paper page
- 10.1016/S0014-5793(98)00919-3 · DOI
- 10.1006/excr.1998.4225 · DOI
- 10.1046/j.1523-1747.1998.00352.x · DOI · Paper page
- 10.3322/canjclin.57.1.43 · DOI · Paper page
- 10.3322/canjclin.52.1.23 · DOI · Paper page
- 10.1007/s11033-014-3769-2 · DOI
- 10.1128/MCB.16.12.6985 · DOI · Paper page
- 10.1111/j.1757-7861.2009.00019.x · DOI
- Jobin C., 1999, J. Immunol., 163, 3474, 10.4049/jimmunol.163.6.3474 · DOI · Paper page
- 10.1007/BF03032599 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-2045 · DOI
- 10.1158/0008-5472.CAN-09-2045 · DOI
- 10.1016/j.fct.2014.02.024 · DOI
- 10.2174/1568009053202081 · DOI · Paper page
- Kawamori T., 1999, Cancer Res., 59, 597
- 10.1016/S0065-230X(08)61026-X · DOI · Paper page
- 10.1016/j.colsurfb.2015.05.007 · DOI
- 10.1002/lary.20582 · DOI
- 10.3390/pharmaceutics7020043 · doi:10.3390/pharmaceutics7020043
- 10.1002/mc.22332 · DOI
- 10.1007/s11626-014-9791-9 · DOI
- 10.1158/1078-0432.CCR-11-1272 · DOI
- 10.1158/1078-0432.CCR-11-1272 · DOI
- 10.1210/en.2011-1413 · DOI
- 10.3892/or.2015.3865 · DOI
- 10.1016/S0006-2952(00)00544-X · DOI
- 10.1007/s10147-012-0387-7 · doi:10.1007/s10147-012-0387-7
- 10.1016/0167-4889(94)90299-2 · DOI
- 10.1016/j.molonc.2014.01.005 · DOI · Paper page
- 10.1016/S0006-2952(97)00557-1 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-4257 · DOI · Paper page
- 10.1158/0008-5472.CAN-10-2318 · doi:10.1158/0008-5472.can-10-2318
- 10.1158/1541-7786.MCR-05-0140 · DOI
- 10.1111/j.1749-6632.2009.03699.x · doi:10.1111/j.1749-6632.2009.03699.x
- 10.1089/10799900050198372 · DOI
- 10.1177/1534735415588930 · DOI
- Lee D. S., 2009, Anticancer Res., 29, 5039
- 10.1590/S1677-55382009000500012 · DOI
- Lestari, M. L. A. D. and Indrayanto, G. (2014). Profiles of Drug Substances, Excipients and Related Methodology, pp. 113–204. Academic Press, Cambridge, Massachusetts, United States.
- 10.1016/j.jnutbio.2014.03.014 · doi:10.1016/j.jnutbio.2014.03.014
- 10.1016/j.mrgentox.2014.07.001 · doi:10.1016/j.mrgentox.2014.07.001
- 10.1007/BF02857359 · doi:10.1007/bf02857359
- 10.1002/cncr.21300 · DOI · Paper page
- 10.2174/2210290601102010028 · DOI · Paper page
- 10.1002/ptr.5167 · DOI · Paper page
- 10.1080/01635581.2011.596645 · DOI
- 10.3390/ijms150915754 · DOI
- 10.1007/BF02830706 · doi:10.1007/bf02830706
- 10.1016/S0197-4580(00)82753-0 · DOI
- 10.1007/s11010-006-9302-8 · DOI · Paper page
- Lin J.-K., 2001, Proc. Natl. Sci. Counc. Repub. China B, 25, 59
- 10.1111/j.1349-7006.2009.01220.x · DOI
- 10.1158/1078-0432.CCR-06-3072 · DOI · Paper page
- 10.3892/mmr.2015.3332 · DOI
- 10.1124/mol.111.072512 · doi:10.1124/mol.111.072512
- 10.1158/1078-0432.CCR-05-0301 · DOI · Paper page
- 10.1093/carcin/14.2.293 · DOI · Paper page
- 10.1016/j.toxlet.2014.09.014 · DOI
- 10.1002/ijc.22055 · DOI
- 10.1093/carcin/21.5.921 · DOI · Paper page
- 10.1158/1538-7445.AM2011-2936 · doi:10.1158/1538-7445.am2011-2936
- 10.1111/j.1742-4658.2006.05458.x · DOI
- 10.1007/s00280-006-0355-x · DOI · Paper page
- 10.1016/j.jhep.2015.04.018 · DOI · Paper page
- 10.18632/oncotarget.2534 · DOI
- 10.1016/j.ejca.2008.12.030 · DOI
- 10.1007/s11523-014-0321-1 · DOI
- 10.1371/journal.pone.0085550 · DOI
- 10.1016/j.biortech.2008.10.041 · DOI
- 10.2174/138920012798356952 · DOI
- 10.1016/j.cbi.2013.12.006 · DOI
- 10.1016/S0022-5347(02)80294-4 · doi:10.1016/s0022-5347(02)80294-4
- 10.1016/S0014-5793(01)02376-6 · DOI · Paper page
- 10.1016/0306-3623(95)02025-X · DOI
- 10.1038/sj.onc.1206048 · DOI · Paper page
- 10.1038/sj.onc.1204997 · DOI · Paper page
- 10.1016/j.canlet.2014.12.007 · DOI
- 10.1016/j.bmcl.2007.06.083 · doi:10.1016/j.bmcl.2007.06.083
- Nakamura K., 2002, Int. J. Oncol., 21, 825
- 10.1007/BF00420910 · DOI · Paper page
- 10.1006/phrs.1998.0425 · doi:10.1006/phrs.1998.0425
- 10.1593/neo.06409 · DOI
- 10.1006/phrs.1998.0403 · DOI
- 10.1006/niox.2000.0305 · DOI
- 10.3109/01480545.2012.726626 · DOI
- 10.3322/canjclin.55.2.74 · DOI · Paper page
- 10.1161/01.ATV.17.12.3406 · DOI
- 10.1016/S1357-2725(02)00057-2 · DOI
- 10.1177/0194599811400711 · doi:10.1177/0194599811400711
- Piguet P., 1989, Eur. Cytokine Netw., 1, 257
- 10.1084/jem.170.3.655 · DOI · Paper page
- 10.1006/excr.1999.4480 · DOI
- 10.1371/journal.pone.0085796 · doi:10.1371/journal.pone.0085796
- 10.1016/0378-8741(90)90094-A · doi:10.1016/0378-8741(90)90094-a
- 10.1016/j.bbrc.2005.12.014 · DOI
- 10.1023/A:1006170224414 · DOI
- 10.1007/s13277-014-1840-1 · DOI
- 10.1007/s11010-015-2330-5 · DOI
- 10.1006/jsre.1999.5719 · DOI
- 10.1093/carcin/14.11.2219 · DOI · Paper page
- 10.1006/phrs.1998.0343 · DOI
- 10.1007/BF00926033 · DOI · Paper page
- Roy M., 2002, Asian Pac. J. Cancer Prev., 3, 61
- 10.7314/APJCP.2014.15.3.1403 · DOI
- 10.4155/tde.11.97 · DOI
- 10.1038/sj.bjc.6605039 · DOI · Paper page
- 10.1158/1940-6207.CAPR-11-0267 · DOI · Paper page
- 10.1093/ecam/nem043 · DOI · Paper page
200 of 285 shown
Cited by
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Giordano, A., & Tommonaro, G. (2019) · Nutrients · doi:10.3390/nu11102376 · Cited by 1,000
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
Seca, A., & Pinto, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010263 · Cited by 686
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Metadata
- Authors
- Imran, M., Ullah, A., Saeed, F., Nadeem, M., Arshad, M. U., & Suleria, H. A. R.
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2017-08-31
- Volume
- 58
- Issue
- 8
- Pages
- 1271-1293
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W2554653187
- Cited by
- 97
- References
- 6
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cucurmin, anticancer, & antitumor perspectives: A comprehensive review. https://app.cochat.ai/papers/10.1080/10408398.2016.1252711
- The paper
- Imran, M., Ullah, A., Saeed, F., Nadeem, M., Arshad, M. U., & Suleria, H. A. R. (2018). Cucurmin, anticancer, & antitumor perspectives: A comprehensive review. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2016.1252711
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.